Plus   Neg

BioMarin: Vosoritide Phase 3 Study Shows Positive Results - Quick Facts

BioMarin Pharmaceutical Inc. (BMRN) reported positive final results from its double-blind, placebo-controlled Phase 3 study evaluating the efficacy and safety of vosoritide in Children with achondroplasia. In the study, placebo-adjusted increase in growth velocity was 1.6 cm/yr. Vosoritide was generally well tolerated.

Based on the results, the company plans to meet with health authorities in the first half of 2020 to discuss plans for submitting marketing applications.

"The placebo-controlled study demonstrated a strong increase in growth velocity across the broad population studied. These results when combined with the long-term benefits seen in the phase 2 study provide hope for a significant and sustained benefit for children with achondroplasia," said Hank Fuchs, President Worldwide Research and Development at BioMarin.

Shares of BioMarin Pharma were up 7% in pre-market trade on Monday.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Cargill, a privately-held food and agriculture company, said Monday it will launch new private label plant-based patties and ground products in order to meet the growing global demand for protein. The new products will hit retailers and restaurants in early April. Cargill said that the plant-based protein products were developed through extensive consumer research and innovation. Taro Pharmaceuticals U.S.A., Inc., the U.S.-based business of Israeli Pharma firm Taro Pharmaceutical Industries, Ltd., recalled certain lots of seizure medication Phenytoin in the form of oral suspension for potential underdosing or overdosing, the U.S. Food and Drug Administration said in a statement. The company found that the oral suspension may not re-suspend when shaken. The Federal Trade Commission (FTC) is in the process of sending out refund checks to consumers who were allegedly misled by Office Depot, Inc. and its software provider Support.com, Inc., into buying computer repair products and services. Out of $34 million, being the total amount of checks, Office Depot paid $25 million and Support.com paid $10 million as part of 2019 settlement.
Follow RTT